John McKew Net Worth & Insider Trades
John McKew - Chief Scientific Officer, Lumos Pharma, Inc
What is John McKew's Net Worth?
The current estimated net worth of Lumos Pharma, Inc's Chief Scientific Officer, John McKew, is estimated to be about $81.15K . John McKew owns about 23,207 units of Lumos Pharma, Inc common stock. In the last 3 years at Lumos Pharma, Inc, John McKew has sold an estimated value of $121.57K worth.
What is John McKew's Past Insider Trading?
John McKew's largest purchase order was 2,000 units , worth over $7.04K on February 3, 2023. John McKew's largest sale order was 5,000 units , worth over $40.65K on August 3, 2022. In total, John McKew has made about 11 transactions over 3 years of their time at Lumos Pharma, Inc. John McKew usually trades in April, with the busiest year in 2022 and 2021. The most recent transaction was a sale order of 3,250 units , worth over $10.67K on April 4, 2023.
John McKew
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was John McKew's Salary in 2020?
As Chief Scientific Officer of Lumos Pharma, Inc, John McKew has a total base salary of $436,300 . John McKew received compensation valued at about $1,215,770 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of stock awards of $102,310 , option awards of $365,475 , other earnings, plans or compensations of $276,044 , and other compensation of $35,641 .
What is John McKew's' Mailing Address?
- Mailing address is C/o Lumos Pharma 4200 Marathon Blvd, Ste 200 Austin TX 78756 TX
Lumos Pharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Richard J. Hawkins* | 2020 | $516,380 | $196,750 | $759,063 | $686,336 | $63,500 | $2,222,029 |
| Richard J. Hawkins* | 2019 | $425,000 | - | $136,720 | $178,500 | - | $740,220 |
| John C. McKew* | 2020 | $436,300 | $102,310 | $365,475 | $276,044 | $35,641 | $1,215,770 |
| John C. McKew* | 2019 | $412,000 | - | - | $144,200 | - | $556,200 |
| Eugene P. Kennedy, M.D.** | 2020 | $459,638 | $70,830 | $253,021 | $300,770 | $62,040 | $1,146,299 |
| Eugene P. Kennedy, M.D.** | 2019 | $437,750 | - | $234,835 | $192,610 | $57,299 | $922,494 |
| Carl W. Langren | 2020 | $389,025 | $70,830 | $253,021 | $269,926 | $59,040 | $1,041,842 |
| Carl W. Langren | 2019 | $370,500 | - | $234,835 | $163,020 | $54,467 | $822,822 |
| Bradley J. Powers | 2020 | $380,000 | $35,415 | $140,567 | $245,236 | $51,842 | $853,060 |
| Bradley J. Powers | 2019 | $345,000 | - | $100,613 | $151,800 | $45,365 | $642,778 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623421000050/lumo-def14ax2021.htm
What are Lumos Pharma, Inc's Past Insider Trades?
Lumos Pharma, Inc's most recent insider trade came on April 4, 2023 by John McKew who sold 3,250 units worth $10.67K . In the last 2 years, insiders at Lumos Pharma, Inc have sold an estimated value of $195.66K and bought an estimated value of $3.21M worth of shares. Insider trading is most common in April, with the busiest year in 2021. The most active traders at the company are John McKew, Chief Scientific Officer, Kevin Lalande, Director, and Lori Lawley, Chief Financial Officer .
LUMOS PHARMA, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||